Form 8-K - Current report:
SEC Accession No. 0001564590-22-011090
Filing Date
2022-03-18
Accepted
2022-03-18 17:01:49
Documents
12
Period of Report
2022-03-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20220314.htm   iXBRL 8-K 36263
  Complete submission text file 0001564590-22-011090.txt   166902

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220314.xsd EX-101.SCH 5717
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220314_lab.xml EX-101.LAB 19422
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220314_pre.xml EX-101.PRE 11600
6 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20220314_htm.xml XML 3549
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 22753271
SIC: 2834 Pharmaceutical Preparations